When looking at the temporal sequence of somatic mutation acquisition, it seems that while ASXL1 or EZH2 mutation acquisition prior to JAK2 V617F leads to the development of ET or primary MF, the late emergence of those mutations was more likely to constitute a PV phenotype in patients [114]. Here, JAK2 is linked to acquired polycythemia vera.